60 Degrees Pharmaceuticals Inc
SXTPW0.052USD
0.000
Close 11/04, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of 60 Degrees Pharmaceuticals Inc Company
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
60 Degrees Pharmaceuticals Inc Info
Ticker SymbolSXTPW
Company name60 Degrees Pharmaceuticals Inc
IPO dateJul 12, 2023
CEODr. Ll S. Dow, Ph.D.
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address1025 Connecticut Avenue Nw
CityWASHINGTON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code20036
Phone12023275422
Websitehttps://60degreespharma.com/
Ticker SymbolSXTPW
IPO dateJul 12, 2023
CEODr. Ll S. Dow, Ph.D.
Company Executives of 60 Degrees Pharmaceuticals Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
--
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
--
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
--
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
--
--
Mr. Patrick Gaynes
Mr. Patrick Gaynes
Investor Relations Officer
Investor Relations Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
--
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
--
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
No Data
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
